References
- Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Gin Microbiol Rev 2000; 13: 236–301.
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
- Chakrabarti A, Das A, Sharma A, et al. Ten years' experience in zygomycosis at a tertiary care center in India. J Infect 2001; 42: 261–266.
- Tedder M, Spratt JA, Anstadt MP, et al. Pulmonary Mucormy-cosis: Results of medical and surgical therapy. Ann Thorac Surg 1994; 57: 1044–1050.
- Blitzer A, Lawson W, Meyers BR, et al. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 1980; 90: 635–648.
- Brown AE. Overview of fungal infections in cancer patients. Semin Oncol 1990; 17: 2–5.
- Bodey GP, Anaissie E, Gutterman J, et al. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Gin Infect Dis 1993; 17: 705–707.
- Hagensee ME, Bauwens JE, Kjos B, et al. Brain abscess following marrow transplantation: experience at the Fred Hutchinson cancer research center, 1984-1992. Gin Infect Dis 1994; 19: 402–408.
- Ryan RM, Warren RE. Rhinocerebral mucormycosis due to Absidia corymbifera. Infection 1987; 15: 120–121.
- Earhart KC, Rhinocerebral Mucormycosis, in www.emedicine. com/med/topic2026.htm
- Gebhard F, Chastagner P, Maillot D, et al. Favorable outcome of orbital nasal sinus mucormycosis complicating the inductiontreatment of acute lymphoblastic leukemia. Arch Pediatr 1995; 2: 47–51.
- Ryan M, Yeo S, Maguire A, et al. Rhinocerebral zygomycosis in childhood acute lymphoblastic leukaemia. Eur J Pediat 2001; 160: 235–238.
- Leong KW, Crowley B, White B, et al. Cutaneous mucormycosis due to Abs idia corymbifera occurring after bone marrow trans-plantation. Bone Marrow Transplant 1997; 19: 513–515.